News

"Cutting reimbursements for procedures that reduce strokes, such as the 27% in the proposed rule to transcatheter left atrial appendage occlusion (LAAO), will only increase the risk of hospitalization and long-term disability for vulnerable...

Kardium Inc., the developer of the Globe® Pulsed Field System – an innovative treatment for atrial fibrillation (AF) – has raised US$250 million in a new financing round.

New flow rate guidance designed to optimize irrigation and support consistent procedural outcomes; 10,000+ VARIPULSE global procedures with low adverse event rate reinforces platform’s strong safety profile

Boston Scientific Corporation has received FDA approval to expand the instructions for use labeling for the FARAPULSE™ Pulsed Field Ablation System.

OMRON Healthcare today issued an urgent health message across the U.S. to raise public awareness of rapidly increasing risks and rising mortality rates associated with arrhythmias such as atrial fibrillation.